首页> 美国卫生研究院文献>other >Exploring the miRNA-mRNA Regulatory Network in Clear Cell Renal Cell Carcinomas by Next-Generation Sequencing Expression Profiles
【2h】

Exploring the miRNA-mRNA Regulatory Network in Clear Cell Renal Cell Carcinomas by Next-Generation Sequencing Expression Profiles

机译:通过下一代测序表达谱探索透明细胞肾细胞癌中的miRNA-mRNA调控网络

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Altered microRNA (miRNA) expression is a hallmark of many cancer types. The combined analysis of miRNA and messenger RNA (mRNA) expression profiles is crucial to identifying links between deregulated miRNAs and oncogenic pathways. Therefore, we investigated the small non-coding (snc) transcriptomes of nine clear cell renal cell carcinomas (ccRCCs) and adjacent normal tissues for alterations in miRNA expression using a publicly available small RNA-Sequencing (sRNA-Seq) raw-dataset. We constructed a network of deregulated miRNAs and a set of differentially expressed genes publicly available from an independent study to in silico determine miRNAs that contribute to clear cell renal cell carcinogenesis. From a total of 1,672 sncRNAs, 61 were differentially expressed across all ccRCC tissue samples. Several with known implications in ccRCC development, like the upregulated miR-21-5p, miR-142-5p, as well as the downregulated miR-106a-5p, miR-135a-5p, or miR-206. Additionally, novel promising candidates like miR-3065, which i.a. targets NRP2 and FLT1, were detected in this study. Interaction network analysis revealed pivotal roles for miR-106a-5p, whose loss might contribute to the upregulation of 49 target mRNAs, miR-135a-5p (32 targets), miR-206 (28 targets), miR-363-3p (22 targets), and miR-216b (13 targets). Among these targets are the angiogenesis, metastasis, and motility promoting oncogenes c-MET, VEGFA, NRP2, and FLT1, the latter two coding for VEGFA receptors.
机译:改变的microRNA(miRNA)表达是许多癌症类型的标志。 miRNA和信使RNA(mRNA)表达谱的组合分析对于鉴定失调的miRNA与致癌途径之间的联系至关重要。因此,我们使用可公开获得的小RNA测序(sRNA-Seq)原始数据集,调查了9个透明细胞肾细胞癌(ccRCCs)和邻近正常组织的小非编码(snc)转录组,以改变miRNA的表达。我们构建了一个失调的miRNA网络和一组差异表达的基因,该基因可从一项独立研究中公开获得,以通过计算机分析确定有助于透明细胞肾细胞癌变的miRNA。在总共1,672个sncRNA中,在所有ccRCC组织样本中差异表达了61个。某些在ccRCC开发中具有已知影响的化合物,例如上调的miR-21-5p,miR-142-5p以及下调的miR-106a-5p,miR-135a-5p或miR-206。此外,像miR-3065这样的新型有前途的候选药物,即在这项研究中检测到目标NRP2和FLT1。相互作用网络分析揭示了miR-106a-5p的关键作用,其丢失可能有助于上调49个靶mRNA,miR-135a-5p(32个靶),miR-206(28个靶),miR-363-3p(22目标)和miR-216b(13个目标)。这些靶标中有促进血管生成,转移和运动性的癌基因c-MET,VEGFA,NRP2和FLT1,后两个编码VEGFA受体。

著录项

  • 期刊名称 other
  • 作者单位
  • 年(卷),期 -1(2014),-1
  • 年度 -1
  • 页码 948408
  • 总页数 11
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号